1. Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium
2. Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
3. Department of Development and Regeneration, University of Leuven, Belgium
4. Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
5. Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan
6. Department of Pediatric Surgery and Intensive Care, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
7. Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium
8. Department of Pharmacology, Maastricht University, Maastricht, The Netherlands
9. Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands